CytomX Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES
Last updated:
Abstract:
The invention relates generally to compositions and methods for conjugating antibodies and activatable antibodies, and methods of partially reducing antibodies and/or activatable antibodies prior to conjugation, e.g., thiol-based conjugation, with an agent, e.g., a therapeutic and/or diagnostic agent.
Status:
Application
Type:
Utility
Filling date:
9 Apr 2021
Issue date:
24 Mar 2022